Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000886163-11-000011)

Filing Details

Accession Number:: 0000886163-11-000011
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-02-18 17:38:42
Reporting Period:: 2011-02-16

Filing Date:: 2011-02-18
Accepted Time:: 2011-02-18 17:38:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
886163	Ligand Pharmaceuticals Inc	LGND	Pharmaceutical Preparations (2834)	770160744

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1392266	S Charles Berkman	11085 North Torrey Pines Road, Suite 300 La Jolla CA 92037	Vp, Gen. Counsel & Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-02-16	5,000	$9.75	11,696	No	4	S	Direct
Common Stock	Acquisiton	2011-02-17	3,000	$0.00	14,696	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Option (right to buy)	Acquisiton	2011-02-17	10,221	$10.05	10,221	$10.05
Common Stock	Non-Qualified Stock Option (right to buy)	Acquisiton	2011-02-17	4,779	$10.05	4,779	$10.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,221		2021-02-17	No	4	A	Direct
4,779		2021-02-17	No	4	A	Direct

Footnotes

Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Optioned Shares per month thereafter.